Back to Search
Start Over
Brief Report: Efficacy and Safety of Oral Islatravir Once Daily in Combination With Doravirine Through 96 Weeks for Treatment-Naive Adults With HIV-1 Infection Receiving Initial Treatment With Islatravir, Doravirine, and Lamivudine.
- Source :
- JAIDS: Journal of Acquired Immune Deficiency Syndromes; Sep2022, Vol. 91 Issue 1, p68-72, 5p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 15254135
- Volume :
- 91
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- JAIDS: Journal of Acquired Immune Deficiency Syndromes
- Publication Type :
- Academic Journal
- Accession number :
- 158544867
- Full Text :
- https://doi.org/10.1097/QAI.0000000000002879